Cargando…
Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.
Tumour S-phase fraction, but not the apoptotic fraction, had prognostic value in 92 patients with B-cell non-Hodgkin's lymphoma (P < 0.0001 and P = 0.85 respectively). Multivariate analysis showed that S-phase fraction was the strongest prognostic indicator in all cases (P = 0.0003, relative...
Autores principales: | Stokke, T., Smeland, E. B., Kvaløy, S., Holte, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150310/ https://www.ncbi.nlm.nih.gov/pubmed/9667655 |
Ejemplares similares
-
Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.
por: Stokke, T., et al.
Publicado: (1998) -
Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma
por: Stokke, T, et al.
Publicado: (2001) -
Identification of Highly Methylated Genes across Various Types of B-Cell Non-Hodgkin Lymphoma
por: Bethge, Nicole, et al.
Publicado: (2013) -
Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells
por: Tamayo-Orbegozo, Estíbaliz, et al.
Publicado: (2017) -
High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells
por: Blystad, AK, et al.
Publicado: (2001)